Finance

Beta
Lists
JANX:NASDAQ
Janux Therapeutics Inc
$13.36
-2.91%
(-0.40) 1D
$13.36
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JANX...
Open
$13.76
High
$13.82
Low
$13.16
Mkt. cap
814.75M
Avg. vol.
917.47K
Volume
490.59K
52-wk high
$35.25
52-wk low
$12.12
EPS
-$1.84
Beta
2.53
Shares outstanding
60.98M
No. of employees
108
Open
$13.76
High
$13.82
Low
$13.16
Mkt. cap
814.75M
Avg. vol.
917.47K
Volume
490.59K
52-wk high
$35.25
52-wk low
$12.12
EPS
-$1.84
Beta
2.53
Shares outstanding
60.98M
No. of employees
108
Analyst outlook
Analyst Ratings
Based on 13 analysts giving stock ratings to JANX in the past 3 months
Strong Buy
Buy
11
Hold
1
Sell
1
12 month forecast
Based on 13 Wall Street analysts offering 12 month price targets for JANX in the last 3 months.
Highest
Current $13.36
$60.00 (+349.10%)
Average
$31.42 (+135.18%)
Lowest
$14.00 (+4.79%)
News stories
From sources across the web
About Janux Therapeutics Inc
CEO-
Employees108
Founded2017
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
10.00M
-
3.73M
Cost of goods sold
29.18M
34.63M
31.55M
26.81M
Cost of revenue
29.18M
34.63M
31.55M
26.81M
Research and development expenses
5.49M
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.45M
10.62M
10.85M
11.13M
Operating expense
15.94M
10.62M
10.85M
11.13M
Total operating expenses
45.12M
45.25M
42.40M
37.95M
Operating income
-45.12M
-35.25M
-42.40M
-34.21M
Other non operating income
-
-
-
-
EBT including unusual items
-33.86M
-24.31M
-31.95M
-24.36M
EBT excluding unusual items
-33.86M
-24.31M
-31.95M
-24.36M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-33.86M
-24.31M
-31.95M
-24.36M
Net profit margin
-
-243.13%
-
-652.59%
Earnings per share
-0.55
-0.39
-0.51
-0.39
Interest and investment income
11.26M
10.94M
10.46M
9.85M
Interest expense
-
-
-
-
Net interest expenses
11.26M
10.94M
10.46M
9.85M
Depreciation and amortization charges
-
-
-
-
EBITDA
-44.58M
-34.75M
-41.93M
-33.74M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more